Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to the medical countermeasures.
2026 · 3rd Quarter (July 1 - Sep 30)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- THE NICKLES GROUP, LLC
- Filing UUID
- 94a6b59c-a815-46db-8e5b-75461d473592
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Most Favored Nation drug pricing.
Issues related to tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.